Biotechnology Derived Proteins

Most products derived by biotechnology will be immunogenic in animals. Therefore, the FDA requires measurement of antibodies directed toward the biotechnology-derived product, usually as an endpoint in repeat dose toxicity studies. For regulatory purposes, the appearance of antibodies is correlated with changes in the pharmacokinetic or pharmacodynamic parameters of the test compound. These data allow antibody classification as either neutralizing or nonneutralizing.

The antibody response is considered insignificant when certain criteria are fulfilled. The criteria are (1) there is no dose-related immune response to the biotechnology-derived product, (2) the response is variable and occurs in only a small number of test animals, and (3) pharmacological or toxicological effects occur only in a small number of animals.

How To Bolster Your Immune System

How To Bolster Your Immune System

All Natural Immune Boosters Proven To Fight Infection, Disease And More. Discover A Natural, Safe Effective Way To Boost Your Immune System Using Ingredients From Your Kitchen Cupboard. The only common sense, no holds barred guide to hit the market today no gimmicks, no pills, just old fashioned common sense remedies to cure colds, influenza, viral infections and more.

Get My Free Audio Book

Post a comment